Eladocagene Exuparvovec
ATC A16AB26 · 6 markets · 6 records
US 1 records · 1 strengths
Records without a stated strength · 1 KEBILIDI
GB 1 records · 1 strengths
- 0.5 mLinjectionUpstaza 280 giga vector genomes/0.5ml solution for infusion vials
TW 1 records · 1 strengths
- 0.5 mLinjectionUpstaza 2.8 × 10^11 vector genomes (vg)/0.5 mL solution for infusion展世達輸注溶液
HK 1 records · 1 strengths
Records without a stated strength · 1 UPSTAZA SOLUTION FOR INFUSION 2.8 X 10^11 VECTOR GENOMES/0.5ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Upstaza
| Strength / form / release | US | GB | TW | HK | EU |
|---|---|---|---|---|---|
| 0.5 mL injection | Upstaza 280 giga vector genomes/0.5ml solution for infusion vials | Upstaza 2.8 × 10^11 vector genomes (vg)/0.5 mL solution for infusion 展世達輸注溶液 | |||
unknown | UPSTAZA SOLUTION FOR INFUSION 2.8 X 10^11 VECTOR GENOMES/0.5ML | Upstaza | |||
liquid | KEBILIDI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.